Key Takeaways
- Volume-led growth, price-led revenue miss: Sales rose 17% YoY on 16% volume growth, but management walked back the FY25 ₹900 crore revenue target because selling prices are dropping.
- Gross margin surprise: Gross margins jumped to ~45-47% from 35% YoY, driven by a richer product mix within the industrial segment and early contribution from the new Pakhajan facility.
- Pakhajan ramp is the story, but it is running late: Utilization hit only 15% in Q2 vs. the 20% expected, as customer approvals are taking longer. The Q4 target of 60% is still on, but the path is back-end loaded.
- Balance sheet pivot ahead: Debt repayment begins April 2025, with a target to bring debt-to-EBITDA close to 3x by FY26, marking a shift from the heavy capex cycle.
- What to watch next quarter: Whether Pakhajan utilization jumps to the promised 35-40% in Q3, any stabilization in selling prices, and the revised FY25 revenue target in the January call.
Pakhajan Ramp-Up: The Central Driver
- Utilization missed the mark: Q2 utilization was 15%, below the anticipated 20%, because customer final approvals are taking longer than expected as clients make complex supply chain decisions and sometimes wait for their own customers' approvals.
- Back-end loaded ramp: Management expects Q3 utilization between 35% and 40%, then a jump to 60% in Q4, assigning a "very high probability" to hitting that Q4 target. The FY26 target is 90% utilization for the full year.
- Margin contribution already visible: The facility has started producing and selling more, positively impacting gross margins, though management declines to disclose plant-wise revenue or EBITDA.
- Capex efficiency built in: Phase 1 capex of ₹600 crores included ₹400 crores for shared utilities and infrastructure that will serve future expansions, so incremental capex for equivalent capacity will be only ~₹200 crores, making ROCE on future phases very high.
- Next expansion gated: The next capex round is not on the table until 70% utilization is achieved, expected by Q1 FY26; a decision on whether to fund it with equity or other means will be made then.
Parag Jhaveri: "Anything is too premature to speak at this moment as the next capex round is not on the table as of now, unless and until we achieve 70%."
Revenue: Volume Strength, Price Weakness
- Volume growth intact, pricing the drag: Sales volumes grew 18% YoY while revenues grew 16% YoY; the product mix within industrial chemicals helped maintain the top line despite downward pricing pressure, but management is clear that selling price drops are the reason the ₹900 crore FY25 target will be missed.
- Customers are cautious: Buyers in Europe and the USA are deferring commitments because they expect the next purchase to be cheaper, creating a competitive environment with price dropping.
- Pricing at the floor: Management believes chemical pricing is at the bottom and should not fall further unless something dramatic happens globally, though they see only "sparks" of price increases and volatility at the lower band.
- Industrial segment is the engine: The industrial chemicals division is the driving force for Yasho, with 30-40% volume growth needed to achieve sales targets; it will carry the company through the next 3-5 year growth plan and is helping grow market share and reach a larger customer base.
- FY25 target formally walked back: Management does not expect to touch ₹900 crores purely because of selling price drops; a revised target will be given in the January call, with management wanting to be cautious and not over-commit in the current market.
Parag Jhaveri: "I don't think so. We will be able to touch the INR900 crores purely because of the selling price dropping."
Margins: Mix Shift Delivers
- Gross margin expansion is the standout: Gross margins reached ~45-47%, up from 35% YoY, despite a similar broad split between industrial and other segments, because within the industrial segment there are over 100 products and the company is pushing higher-margin products alongside conventional ones.
- Pakhajan adds a layer: The new facility's contribution is also positively impacting gross margins, with better contribution from the unit cited as one of two factors behind the improvement.
- EBITDA guided steady, not spectacular: Management expects EBITDA to remain in the 17-19% range for the next few quarters while Vapi operations stay stable, and is cautious about crossing 19% unless market circumstances support it.
- Gross margin floor set: Management is striving for gross margins around 40%, with 38-40% as the minimum level with the new capacity at Pakhajan, and sees room for further improvement from there.
- Fixed cost absorption ahead: As Pakhajan ramps up, fixed costs will be covered and expenses rationalized, improving overall margins.
Parag Jhaveri: "I did not say that we will grow at 19%. I said between 17% to 19%. So, we are cautious here. I'll be happy to cross 19% also. But the market circumstances should support us here."
Balance Sheet & Capital Allocation
- Debt composition clarified: Of ₹580 crore total debt, only ₹330 crores is long-term debt; the rest is working capital, which is not repaid.
- Repayment timeline set: Debt repayment begins from April 2025, with ₹25-30 crores planned for FY26 and year-on-year repayment thereafter.
- Leverage target: Management expects debt-to-EBITDA to come close to 3x by FY26, though they acknowledge it is not entirely in their hands and they will work toward it aggressively.
- Working capital normalization: Working capital days are expected to come back to 110-115 days by March.
- FY26 revenue commitment held: Management is still holding the committed ₹1,250 crores for FY26, noting that target was already on the lower band side so no challenge is seen.
Parag Jhaveri: "That's not in my hand. I don't have crystal ball, but we'll definitely work towards that aggressively."
Market Position & Competitive Dynamics
- Market share gains continue: The company continues to gain market share despite a sector slowdown, with export and domestic shares maintained consistently within ±1% variation and equal growth in both markets.
- US subsidiary opens a direct channel: The US subsidiary will be operational in the next few weeks, serving as a distribution hub because smaller and even some large customers are not comfortable planning 90-120 days in advance; having stock in the US allows reaching end-users directly and making more money, similar to the European subsidiary model.
- Geographic expansion underway: The company is working to expand reach in Central America and Latin America.
- No competitor plant closures seen: Management has not come across any of their company's chemical plants shutting down in Europe; they only know of one or two temporary issues on certain sites.
- Customer base is broad: The company has more than 2,000 customers, though management does not have an exact split by category readily available.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Pakhajan utilization | 35% to 40% | Q3 FY25 |
| Pakhajan utilization | 60% ("very high probability") | Q4 FY25 |
| Pakhajan utilization | 90% for the full year | FY26 |
| EBITDA margin | 17% to 19% range | Next few quarters |
| Gross margin floor | 38% to 40% minimum | Ongoing, with new Pakhajan capacity |
| FY26 revenue | ₹1,250 crores (held, no challenge seen) | FY26 |
| Debt repayment start | ₹25-30 crores in FY26, year-on-year thereafter | From April 2025 |
| Debt-to-EBITDA | Close to 3x | FY26 |
| Working capital days | 110-115 days | By March 2025 |
| Next capex decision | Gated on 70% utilization; decision on equity vs. other means at that time | Expected Q1 FY26 |
| Revised FY25 revenue target | To be provided | January call |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹167.35 cr, +17% YoY |
| Sales volume growth | 16% YoY |
| EBITDA margin | 18.8%, guidance range of 17%-19% for next few quarters |
| Gross margin | 47%, up from 35% in Q2 FY24 and up 1,100 bps QoQ |
| Export share of sales | 66% |
| Industrial business share of sales | 82% |
| Pakhajan facility utilization | 15%, expected to reach 35%-40% in Q3 FY25 and 60% in Q4 FY25 |
| Pakhajan utilization target FY26 | 90% for the full year |
| FY25 revenue target | Not expected to achieve the earlier ₹900 cr target due to selling price declines |
| FY26 revenue target | ₹1,250 cr, still held |
| Pricing impact | 10%-15% decrease in selling prices |
| Customer count | More than 2,000 |
| Lubricant additive market size | $10 to $12 billion, growing at 3%-4% |
| Debt to EBITDA | 5x, expected to come close to 3x by FY26 |
| Working capital days | ~200 days, expected to return to 110-115 days by March 2025 |
| Long-term debt | ₹330 cr, with ₹25-₹30 cr repayment planned in FY26 |
| Sustainable tax rate | 25.4% |